Pamela K Mcgill, PT Physical Therapist - Orthopedic Medicare: Not Enrolled in Medicare Practice Location: 801 Arnold Ave, Point Pleasant Beach, NJ 08742 Phone: 732-295-8215 Fax: 732-295-1524 |
Next Level Physical Therapy And Wellness Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2120 Edgar Rd, Point Pleasant Beach, NJ 08742 Phone: 732-841-4763 |
Michelle R Germinario, D.P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 801 Arnold Ave, Point Pleasant Beach, NJ 08742 Phone: 732-295-8215 Fax: 732-295-1524 |
Lauren Donovan, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1218 Curtis Ave, Point Pleasant Beach, NJ 08742 Phone: 914-224-9382 |
Lori-ann Gronau, PT, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 801 Arnold Ave, Point Pleasant Beach, NJ 08742 Phone: 732-295-8215 |
News Archive
Patients with coronary heart disease who had higher omega-3 fatty acid blood levels had an associated lower rate of shortening of telomere length, a chromosome marker of biological aging, raising the possibility that these fatty acids may protect against cellular aging, according to a study in the January 20 issue of JAMA.
Lab-on-a-chip (LOC) development has skyrocketed in the last couple of years due to constant efforts in harnessing microfluidics and µTAS to improve the LOC design and function. The distinct advantages that they bestow on applications are pushing the commercial potential of LOCs.
Researchers at the New York University Polytechnic School of Engineering have broken new ground in the development of proteins that form specialized fibers used in medicine and nanotechnology. For as long as scientists have been able to create new proteins that are capable of self-assembling into fibers, their work has taken place on the nanoscale. For the first time, this achievement has been realized on the microscale—a leap of magnitude in size that presents significant new opportunities for using engineered protein fibers.
Researchers have developed a simple tool that predicts virologic response and development of drug resistance in patients receiving HIV treatment, based on how regularly they attend their scheduled health appointments.
› Verified 1 days ago